Bristol-Myers and bluebird report positive data from myeloma study
bb21217 therapy is being evaluated to treat patients with R/RMM. Credit: www.scientificanimations.com.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more